Related Experiment Video

Updated: Aug 14, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

[Hepatitis C following administration of intravenous immunoglobulins]

T Cabrera Chaves1, M A Simón Marco, F Gomollón García

  • 1Servicio de Aparato Digeso, Hospital Miguel Servet, Zaragoza.

Gastroenterologia Y Hepatologia
|June 1, 1996
PubMed

Insights

Intravenous immunoglobulin (IVIg) therapy can transmit hepatitis C virus (HCV) infection. Careful patient selection and donor screening are crucial to prevent HCV transmission during IVIg treatment.

Area of Science:

  • Hepatology
  • Immunology
  • Infectious Diseases

Background:

  • Intravenous immunoglobulins (IVIg) are essential therapeutics for various immune deficiencies and autoimmune conditions.
  • Hepatitis C virus (HCV) poses a significant public health challenge due to its potential for severe liver damage.
  • The risk of pathogen transmission, including HCV, through blood-derived products like IVIg necessitates stringent safety measures.

Observation:

  • This report details five cases of hepatitis C virus infection in patients who received intravenous immunoglobulins.
  • The severity and clinical evolution of HCV infection varied among the affected patients.
  • The cases highlight a potential route of HCV transmission associated with IVIg administration.

Findings:

  • Hepatitis C virus infection can occur following the administration of intravenous immunoglobulins.
  • The study underscores the significant morbidity associated with hepatitis C virus infection.
  • The findings emphasize the critical need for robust donor screening processes for IVIg products.

Implications:

  • Accurate and judicious indication of IVIg is essential, particularly in immunocompromised patients.
  • Enhanced screening of blood donors is paramount to mitigate the risk of transmitting hepatitis C virus.
  • This highlights the importance of balancing the therapeutic benefits of IVIg with the risks of infectious disease transmission.

More Related Videos

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation10:35

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection09:12

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

Related Concept Videos

Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...